In a recent study, novel genetic associations between obesity, colorectal cancer (CRC), and irritable bowel disease (IBD) were identified. CRC is the third most common cancer diagnosis in the world 3 ...

In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has been rising steadily in recent decades. However, a small proportion of the ...

New research has elucidated how an already identified area of the genome contributes to the development of a number of autoimmune or inflammatory diseases, including inflammatory bowel disease (IBD).

Iron deficiency and anemia are common side effects of inflammatory bowel disease (IBD). A study by biomedical scientists at the University of California, Riverside School of Medicine found that a ...

The spatio-temporal evolution of inflammatory bowel disease across the world follows four epidemiological stages: emergence, acceleration in incidence, compounding prevalence and prevalence ...

Study links gut microbiome diversity and genetic variants in inflammatory bowel disease patients to increased risk of mental health disorders, revealing potential biomarkers and therapeutic targets.

A study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic mutation associated with Crohn's disease can worsen iron deficiency and anemia - ...

Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...